Klaria Pharma Holding AB (publ.) (FRA:6FN)
Germany flag Germany · Delayed Price · Currency is EUR
0.0406
-0.0042 (-9.38%)
At close: Nov 28, 2025

FRA:6FN Statistics

Total Valuation

FRA:6FN has a market cap or net worth of EUR 11.61 million. The enterprise value is 11.43 million.

Market Cap11.61M
Enterprise Value 11.43M

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date Nov 21, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 245.98M
Shares Outstanding n/a
Shares Change (YoY) +41.84%
Shares Change (QoQ) +52.05%
Owned by Insiders (%) 10.78%
Owned by Institutions (%) 10.41%
Float 211.46M

Valuation Ratios

PE Ratio n/a
Forward PE 9.10
PS Ratio 12.77
PB Ratio 28.22
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -2.75
EV / Sales 12.49
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.12, with a Debt / Equity ratio of 0.14.

Current Ratio 0.12
Quick Ratio 0.12
Debt / Equity 0.14
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.74

Financial Efficiency

Return on equity (ROE) is -527.01% and return on invested capital (ROIC) is -201.92%.

Return on Equity (ROE) -527.01%
Return on Assets (ROA) -32.66%
Return on Invested Capital (ROIC) -201.92%
Return on Capital Employed (ROCE) -565.67%
Revenue Per Employee 227,280
Profits Per Employee -1.04M
Employee Count4
Asset Turnover 0.18
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +11.54% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +11.54%
50-Day Moving Average 0.04
200-Day Moving Average 0.06
Relative Strength Index (RSI) 50.36
Average Volume (20 Days) 325

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:6FN had revenue of EUR 909,121 and -4.16 million in losses. Loss per share was -0.03.

Revenue909,121
Gross Profit 909,121
Operating Income -2.64M
Pretax Income -4.16M
Net Income -4.16M
EBITDA -1.26M
EBIT -2.64M
Loss Per Share -0.03
Full Income Statement

Balance Sheet

The company has 229,836 in cash and 55,808 in debt, giving a net cash position of 174,027.

Cash & Cash Equivalents 229,836
Total Debt 55,808
Net Cash 174,027
Net Cash Per Share n/a
Equity (Book Value) 411,280
Book Value Per Share 0.00
Working Capital -3.37M
Full Balance Sheet

Cash Flow

Operating Cash Flow -2.83M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -290.63%
Pretax Margin -457.90%
Profit Margin n/a
EBITDA Margin -138.24%
EBIT Margin -290.63%
FCF Margin n/a

Dividends & Yields

FRA:6FN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -41.84%
Shareholder Yield -41.84%
Earnings Yield -35.86%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2